Specify a stock or a cryptocurrency in the search bar to get a summary
Satellos Bioscience Inc.
MSCLFSatellos Bioscience Inc., a biotechnology company, develops regenerative therapeutics to treat degenerative muscle diseases primarily in Canada and Australia. The company uses its proprietary platform MyoReGenX, an automated microscopy system which recapitulates the muscle stem cell environment ex-vivo. Its lead program focuses on the discovery and development of a small molecule drug for the treatment of Duchenne. Satellos Bioscience Inc. was founded in 2018 and is headquartered in Toronto, Canada. Address: Royal Bank Plaza, Toronto, ON, Canada, M5J 2J1
Analytics
WallStreet Target Price
–P/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures MSCLF
Dividend Analytics MSCLF
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History MSCLF
Stock Valuation MSCLF
Financials MSCLF
Results | 2019 | Dynamics |